Work

Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer

Year: 2023

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2023.02.016

Authors: Jocelyn Garcia-Sayre, Yvonne G. Lin, Koji Matsuo, Denice D. Tsao-Wei, Paulette Mhawech-Fauceglia, Stan Louie, Tiange Dong, Marcia A. Ciccone, Laurie L. Brunette-Masi, Huyen Q. Pham, Annie A. Yessaian, Susan G. Groshen, Grace Facio, Marissa Aldana, Laila I. Muderspach, Agustin A. Garcia, Lynda D. Roman

Institutions: University of Southern California, USC Norris Comprehensive Cancer Center, Louisiana State University

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Defense, Eisai, Eisai Incorporated, National Cancer Institute

OpenAlex ID: W4366254566

FWCI:

Cites: 37

Cited by:

Related to: 10